{"id":"W1982905493","doi":"10.1111/dom.12273","title":"Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone","year":2014,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":253,"is_retracted":false,"has_abstract":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Canagliflozin; Metformin; Sitagliptin; Medicine; Placebo; Pioglitazone; Internal medicine; Type 2 diabetes; Endocrinology; Adverse effect; Urology; Diabetes mellitus; Gastroenterology; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001318289,0.000572426,0.001536892,0.000311122,0.0002923493,0.0005379974,0.0003427697,0.0007107574,0.001344745],"category_scores_gemma":[0.001530238,0.0003536503,0.000909513,0.0003711501,0.0002924878,0.0005345226,0.0002311174,0.001159616,0.0002308397],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004124742,"about_ca_system_score_gemma":0.0004874868,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006458102,"about_ca_topic_score_gemma":0.001278071,"domain_scores_codex":[0.9995383,0.0001651988,0.00004421719,0.0001052587,0.00008683358,0.00006016508],"domain_scores_gemma":[0.9992635,0.0001795262,0.0002332991,0.00006286296,0.00004244783,0.000218497],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8050942,0.01416244,0.04274995,0.0004725426,0.00176329,0.0001744065,0.0001699257,0.00108943,0.01073927,0.00004892148,0.0008874352,0.1226482],"study_design_scores_gemma":[0.4007714,0.2955121,0.2918471,0.00009615142,0.002358564,0.0004420081,0.0001329794,0.00321598,0.003684652,0.0001657521,0.001705329,0.00006787923],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972402,0.001786481,0.0001198765,0.0001050132,0.00003319104,0.0001192871,0.00009341491,0.00002210815,0.0004805668],"genre_scores_gemma":[0.9980312,0.0006742465,0.0003217627,0.000219582,0.00006320971,0.0001350035,0.0002166226,0.000004182106,0.0003341788],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001536892,"threshold_uncertainty_score":0.006971896,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005842506116560182,"score_gpt":0.2062542905764193,"score_spread":0.2004117844598591,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}